In collaboration with the Barron Lab, the Santa Maria Lab is developing synthetic analogs for antimicrobial peptides to combat drug-resistant bacteria. Their discovery was recently published in ACS Infectious Diseases.
In collaboration with the Barron Lab, the Santa Maria Lab is developing synthetic analogs for antimicrobial peptides to combat drug-resistant bacteria. Their discovery was recently published in ACS Infectious Diseases.